SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------------------
SCHEDULE 14D-1/A
(Amendment No. 1 (Final Amendment))
Tender Offer Statement Pursuant to Section 14(d)(1)
of the Securities Exchange Act of 1934
----------------------
Schedule 13D/A
(Amendment No. 12 (Final Amendment))
Under the Securities Exchange Act of 1934
----------------------
REN Corporation-USA
(Name of Subject Company)
REN Acquisition Corp.
(Bidder)
COBE Laboratories, Inc.
Gambro AB
Incentive AB
Common Stock, no par value
(Title of Class of Securities)
7596561010
(CUSIP Number of Class of Securities)
------------------------------
Mats Wahlstrom
REN Acquisition Corp.
1185 Oak Street
Lakewood, Colorado 80215
Telephone: (303) 232-6800
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications on Behalf of Bidder)
---------------------------------
Copy to:
Peter D. Lyons, Esq.
Shearman & Sterling
599 Lexington Avenue
New York, New York 10022
Telephone: (212) 848-4000
October 18, 1995
Page 1 of 14 Pages
An Exhibit Index Appears on Page 13
<PAGE>
Cusip No. 7596561010
- --------------------------------------------------------------------------------
1 Name of Reporting Person
S.S. or I.R.S. Identification No. of above Person
REN Acquisition Corp.
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See
Instructions) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF, BK
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) / /
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Tennessee
- --------------------------------------------------------------------------------
7 Aggregate Amount Beneficially Owned by Each Reporting
Person
10,036,221
- --------------------------------------------------------------------------------
8 Check if the Aggregate Amount in Row (7) Excludes
Certain Shares (See Instructions) / /
- --------------------------------------------------------------------------------
9 Percent of Class Represented by Amount in Row (7)
53%
- --------------------------------------------------------------------------------
10 Type of Reporting Person (See Instructions)
CO
Page 2 of 14 Pages
<PAGE>
Cusip No. 7596561010
- --------------------------------------------------------------------------------
1 Name of Reporting Person
S.S. or I.R.S. Identification No. of above Person
COBE Laboratories, Inc.
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See
Instructions) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF, BK
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) / /
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Colorado
- --------------------------------------------------------------------------------
7 Aggregate Amount Beneficially Owned by Each Reporting
Person
10,036,221
- --------------------------------------------------------------------------------
8 Check if the Aggregate Amount in Row (7) Excludes
Certain Shares (See Instructions) / /
- --------------------------------------------------------------------------------
9 Percent of Class Represented by Amount in Row (7)
53%
- --------------------------------------------------------------------------------
10 Type of Reporting Person (See Instructions)
CO
- --------------------------------------------------------------------------------
Page 3 of 14 Pages
<PAGE>
Cusip No. 7596561010
- --------------------------------------------------------------------------------
1 Name of Reporting Person
S.S. or I.R.S. Identification No. of above Person
Gambro AB
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See
Instructions) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF, BK
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) / /
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Sweden
- --------------------------------------------------------------------------------
7 Aggregate Amount Beneficially Owned by Each Reporting
Person
10,036,221
- --------------------------------------------------------------------------------
8 Check if the Aggregate Amount in Row (7) Excludes
Certain Shares (See Instructions) / /
- --------------------------------------------------------------------------------
9 Percent of Class Represented by Amount in Row (7)
53%
- --------------------------------------------------------------------------------
10 Type of Reporting Person (See Instructions)
CO
- --------------------------------------------------------------------------------
Page 4 of 14 Pages
<PAGE>
Cusip No. 7596561010
- --------------------------------------------------------------------------------
1 Name of Reporting Person
S.S. or I.R.S. Identification No. of above Person
Incentive AB
- --------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See
Instructions) (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds (See Instructions)
AF, BK
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Items 2(d) or 2(e) / /
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Sweden
- --------------------------------------------------------------------------------
7 Aggregate Amount Beneficially Owned by Each Reporting
Person
10,036,221
- --------------------------------------------------------------------------------
8 Check if the Aggregate Amount in Row (7) Excludes
Certain Shares (See Instructions) / /
- --------------------------------------------------------------------------------
9 Percent of Class Represented by Amount in Row (7)
53%
- --------------------------------------------------------------------------------
10 Type of Reporting Person (See Instructions)
CO
- --------------------------------------------------------------------------------
Page 5 of 14 Pages
<PAGE>
This Amendment No. 1 (Final Amendment) to the Tender Offer Statement on
Schedule 14D-1 (the "Schedule 14D-1") and Amendment No. 12 (Final Amendment) to
Schedule 13D relates to the offer by REN Acquisition Corp., a Tennessee
corporation ("Purchaser") and a wholly owned subsidiary of COBE Laboratories,
Inc., a Colorado corporation ("Cobe") and an indirect wholly owned subsidiary
of Gambro AB, a Swedish corporation ("Gambro") and an indirect subsidiary of
Incentive AB, a Swedish corporation ("Incentive"), to purchase all outstanding
shares of Common Stock, no par value, not currently owned by Gambro or any of
its affiliates (the "Shares"), of REN Corporation-USA, a Tennessee corporation
(the "Company"), at a price of $20.00 per Share, net to the seller in cash,
upon the terms and subject to the conditions set forth in Purchaser's Offer
to Purchase dated September 19, 1995 (the "Offer to Purchase") and in the
related Letter of Transmittal, copies of which were attached to the Schedule
14D-1 as Exhibits (a)(1) and (a)(2), respectively. The Schedule 14D-1 was
initially filed with the Securities and Exchange Commission on
September 19, 1995.
Capitalized terms used but not defined herein have the meanings ascribed
to such terms in the Offer to Purchase and the Schedule 14D-1.
Page 6 of 14 Pages
<PAGE>
Item 6. Interest in Securities of the Subject Company
Item 6 is hereby amended and supplemented by adding to the end thereof
the following:
At 12:00 midnight, New York City time, on Tuesday, October 17, 1995, the
Offer expired. Based on a preliminary count, approximately 8,355,796 Shares
were tendered pursuant to the Offer, of which 212,229 were tendered pursuant
to notices of guaranteed delivery. Such Shares (including Shares delivered
pursuant to notices of guaranteed delivery) constituted approximately 88%
of the outstanding Shares not already owned by Gambro or any of its affiliates.
On October 18, 1995, effective as of 12:01 a.m., all Shares validly tendered
and not withdrawn prior to the expiration of the Offer were accepted for
payment. The acceptance of such tendered Shares resulted in Gambro and its
affiliates owning approximately 94% of the Shares. A copy of a press release
announcing the expiration of the Offer and the acceptance of validly tendered
Shares is attached hereto as Exhibit (a)(9) and is incorporated herein by
reference in its entirety.
Page 7 of 14 Pages
<PAGE>
Item 11. Material to Be Filed as Exhibits
(a)(9) Press Release issued by Gambro on October 18, 1995 relating to the
expiration of the Offer.
Page 8 of 14 Pages
<PAGE>
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
October 18, 1995
REN ACQUISITION CORP.
By: /s/ Ralph Z. Levy, Jr.
------------------------------
Name: Ralph Z. Levy, Jr.
Title: Vice President
Page 9 of 14 Pages
<PAGE>
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
October 18, 1995
COBE LABORATORIES, INC.
By: /s/ Herbert S. Lawson
------------------------------
Name: Herbert S. Lawson
Title: Chief Financial Officer
Page 10 of 14 Pages
<PAGE>
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
October 18, 1995
GAMBRO AB
By: /s/ Berthold Lindqvist
-------------------------------
Name: Berthold Lindqvist
Title: President
Page 11 of 14 Pages
<PAGE>
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
October 18, 1995
INCENTIVE AB
By: /s/ Mikael Lilius
--------------------------
Name: Mikael Lilius
Title: President
Page 12 of 14 Pages
<PAGE>
EXHIBIT INDEX
<TABLE><CAPTION>
Sequentially
Exhibit Numbered
No. Description Page
- --------- ----------- -------------
<S> <C> <C>
(a)(1) Form of Offer to Purchase dated September 19, 1995 . . . . . . . *
(a)(2) Form of Letter of Transmittal . . . . . . . . . . . . . . . . . . *
(a)(3) Form of Notice of Guaranteed Delivery . . . . . . . . . . . . . . *
(a)(4) Form of Letter to Brokers, Dealers, Commercial Banks, Trust
Companies and Nominees . . . . . . . . . . . . . . . . . . . . . *
(a)(5) Form of Letter from Brokers, Dealers, Commercial Banks, Trust
Companies and Nominees to Clients . . . . . . . . . . . . . . . . *
(a)(6) Form of Guidelines for Certification of Taxpayer Identification
Number on Substitute Form W-9 . . . . . . . . . . . . . . . . . . *
(a)(7) Summary Advertisement as published in The Wall Street Journal on
September 19, 1995 . . . . . . . . . . . . . . . . . . . . . . . *
(a)(8) Text of Press Release issued by COBE on September 13, 1995 . . . *
(a)(9) Text of Press Release issued by Gambro on October 18, 1995
relating to the Offer. . . . . . . . . . . . . . . . . . . . . . 14
(b)(1) Revolving Credit Facility, dated as of May 11, 1993, among
Gambro, BNP Capital Markets Limited (as Arranger), certain banks
named therein and Banque Nationale de Paris (as Agent) . . . . . *
(b)(2) Revolving Credit and Term Loan Facility, dated as of November 30,
1994, among Gambro, BNP Capital Markets Limited (as Arranger),
certain banks named therein and Banque Nationale de Paris (as
Agent) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . *
(b)(3) Uncommitted Line of Credit Agreement, dated as of January 14,
1991, as amended through September 25, 1992, between COBE and
Union Bank of Switzerland, New York Branch . . . . . . . . . . . *
(b)(4) Revolving Credit Facility, dated as of April 28, 1995, between
COBE and Commerzbank, Los Angeles Branch . . . . . . . . . . . . *
(b)(5) Line of Credit Facility, dated as of April 28, 1995, between COBE
and Commerzbank, Los Angeles Branch . . . . . . . . . . . . . . . *
(b)(6) Uncommitted Revolving Credit Facility, dated as of January 7,
1991, as amended through March 29, 1994, between COBE and Societe
Generale, New York Branch. . . . . . . . . . . . . . . . . . . . *
(b)(7) Committed Revolving Credit Facility, dated as of July 29, 1995,
between COBE and The First National Bank of Boston. . . . . . . . *
(b)(8) Discretionary Line of Credit, dated as of July 29, 1995, between
COBE and The First National Bank of Boston. . . . . . . . . . . . *
(c)(1) Agreement and Plan of Merger, dated as of September 12, 1995,
among Gambro, COBE, Purchaser and the Company . . . . . . . . . . *
(c)(2) The Stock Purchase Agreement, dated as of May 11, 1991 as amended
through April 26, 1994, between COBE and the Company . . . . . . *
(c)(3) The Stock Purchase Agreement, dated as of February 9, 1992 as
amended through March 17, 1992, between COBE and the Company . . *
(c)(4) The Stock Purchase Agreement, dated as of July 2, 1992 as amended
through September 15, 1992, between COBE and the Company . . . . *
(c)(5) Employment Agreement, dated as of July 14, 1993, between Lawrence
J. Centella and the Company . . . . . . . . . . . . . . . . . . . *
(c)(6) Letter, dated September 14, 1992, between Juha P. Kokko, M.D., and
the Company . . . . . . . . . . . . . . . . . . . . . . . . . . . *
- -------------------
* Previously Filed
Page 13 of 14 Pages
</TABLE>
GAMBRO GROUP PRESS RELEASE
GAMBRO AB COMPLETES TENDER OFFER FOR
REN CORPORATION-USA
FOR IMMEDIATE RELEASE
New York, October 18, 1995 -- Gambro AB (NASDAQ: GAMBY) announced
today that its subsidiary, COBE Laboratories, Inc. ("COBE"), had completed its
tender offer for REN Corporation-USA (NASDAQ: RENL).
The tender offer expired as scheduled at 12:00 midnight, New York City
time, on Tuesday, October 17, 1995. Based on a preliminary count, 8,355,796
shares were tendered and accepted for payment, representing, together with
the shares already owned by COBE, approximately 94 percent of the outstanding
shares of common stock of Ren Corporation-USA.
Ren Acquisition Corp., a COBE subsidiary established for this purpose,
will merge with REN Corporation-USA. After the merger, COBE will own 100
percent of REN Corporation-USA. Shares of Ren Corporation-USA which were not
tendered into the offer will be cancelled and converted automatically into the
right to receive US$20.00 per share in cash.
For further information, contact:
Inger Larsson, Director Corporate Communications, Gambro AB, Tel: +46-46-169-167
or +46-70-529-9090
Raymond F. McNulty, Managing Director, Citigate, Inc., Tel: +1-212-809-2575
Maria C. Stokes, Associate, Citigate, Inc., Tel: +1-212-809-2575
Page 14 of 14 Pages
